-
1
-
-
3042606744
-
Self-expanding metal stents for gastroduodenal malignancies: Systematic review of their clinical effectiveness
-
Dormann A, Meisner S, Verin N et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy: 2004; 36 543 550
-
(2004)
Endoscopy
, vol.36
, pp. 543-550
-
-
Dormann, A.1
Meisner, S.2
Verin, N.3
-
2
-
-
67349104996
-
Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): A prospective multicenter study
-
van Hooft JE, Uitdehaag MJ, Bruno MJ et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc: 2009; 69 1059 1066
-
(2009)
Gastrointest Endosc
, vol.69
, pp. 1059-1066
-
-
Van Hooft, J.E.1
Uitdehaag, M.J.2
Bruno, M.J.3
-
3
-
-
0037866657
-
Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: Results of a multicenter study
-
Nassif T, Prat F, Meduri B et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy: 2003; 35 483 489
-
(2003)
Endoscopy
, vol.35
, pp. 483-489
-
-
Nassif, T.1
Prat, F.2
Meduri, B.3
-
4
-
-
34447503634
-
Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: A multicenter study
-
Maetani I, Isayama H, Mizumoto Y. Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study. Gastrointest Endosc: 2007; 66 355 360
-
(2007)
Gastrointest Endosc
, vol.66
, pp. 355-360
-
-
Maetani, I.1
Isayama, H.2
Mizumoto, Y.3
-
5
-
-
10644266045
-
Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: Outcomes from a multicenter study
-
Telford JJ, Carr-Locke DL, Baron TH et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc: 2004; 60 916 920
-
(2004)
Gastrointest Endosc
, vol.60
, pp. 916-920
-
-
Telford, J.J.1
Carr-Locke, D.L.2
Baron, T.H.3
-
6
-
-
34447550363
-
Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: Prospective evaluation of results and factors influencing outcome in 213 patients
-
Kim JH, Song HY, Shin JH et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc: 2007; 66 256 264
-
(2007)
Gastrointest Endosc
, vol.66
, pp. 256-264
-
-
Kim, J.H.1
Song, H.Y.2
Shin, J.H.3
-
7
-
-
77949318000
-
Clinical outcomes of self-expandable metal stent and prognostic factors for stent patency in gastric outlet obstruction caused by gastric cancer
-
Cho YK, Kim SW, Hur WH et al. Clinical outcomes of self-expandable metal stent and prognostic factors for stent patency in gastric outlet obstruction caused by gastric cancer. Dig Dis Sci: 2010; 55 668 674
-
(2010)
Dig Dis Sci
, vol.55
, pp. 668-674
-
-
Cho, Y.K.1
Kim, S.W.2
Hur, W.H.3
-
8
-
-
77951888102
-
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The FLAGS trial
-
Ajani JA, Rodriguez W, Bodoky G et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J Clin Oncol: 2010; 28 1547 1553
-
(2010)
J Clin Oncol
, vol.28
, pp. 1547-1553
-
-
Ajani, J.A.1
Rodriguez, W.2
Bodoky, G.3
-
9
-
-
77956262693
-
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
-
Bang YJ, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet: 2010; 376 687 697
-
(2010)
Lancet
, vol.376
, pp. 687-697
-
-
Bang, Y.J.1
Van Cutsem, E.2
Feyereislova, A.3
-
10
-
-
71249128928
-
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: A randomised phase 3 study
-
Boku N, Yamamoto S, Fukuda H et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol: 2009; 10 1063 1069
-
(2009)
Lancet Oncol
, vol.10
, pp. 1063-1069
-
-
Boku, N.1
Yamamoto, S.2
Fukuda, H.3
-
11
-
-
38049047178
-
Capecitabine and oxaliplatin for advanced esophagogastric cancer
-
Cunningham D, Starling N, Rao S et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med: 2008; 358 36 46
-
(2008)
N Engl J Med
, vol.358
, pp. 36-46
-
-
Cunningham, D.1
Starling, N.2
Rao, S.3
-
12
-
-
77953911552
-
Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: A randomized, prospective study
-
Kim CG, Choi IJ, Lee JY et al. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc: 2010; 72 25 32
-
(2010)
Gastrointest Endosc
, vol.72
, pp. 25-32
-
-
Kim, C.G.1
Choi, I.J.2
Lee, J.Y.3
-
13
-
-
0036142264
-
Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: Experience in 36 patients
-
Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol: 2002; 97 72 78
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 72-78
-
-
Adler, D.G.1
Baron, T.H.2
-
14
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada et al.
-
Therasse P, Arbuck SG, Eisenhauer EA. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst: 2000; 92 205 216
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
15
-
-
75149192630
-
Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
-
Lee KH, Hyun MS, Kim HK et al. Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. Cancer Res Treat: 2009; 41 12 18
-
(2009)
Cancer Res Treat
, vol.41
, pp. 12-18
-
-
Lee, K.H.1
Hyun, M.S.2
Kim, H.K.3
-
16
-
-
33744824959
-
Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer
-
Park SR, Choi IJ, Kim CG et al. Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer. J Gastroenterol: 2006; 41 339 346
-
(2006)
J Gastroenterol
, vol.41
, pp. 339-346
-
-
Park, S.R.1
Choi, I.J.2
Kim, C.G.3
-
17
-
-
0034937172
-
The new Japanese classification of gastric carcinoma: Revised explanation of "response assessment of chemotherapy and radiotherapy for gastric carcinomao"
-
Kurihara M, Aiko T. The new Japanese classification of gastric carcinoma: revised explanation of "response assessment of chemotherapy and radiotherapy for gastric carcinomao" Gastric Cancer: 2001; 4 9 13
-
(2001)
Gastric Cancer
, vol.4
, pp. 9-13
-
-
Kurihara, M.1
Aiko, T.2
-
18
-
-
70350507266
-
Improved oral intake after palliative duodenal stenting for malignant obstruction: A prospective multicenter clinical trial
-
Piesman M, Kozarek RA, Brandabur JJ et al. Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial. Am J Gastroenterol: 2009; 104 2404 2411
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 2404-2411
-
-
Piesman, M.1
Kozarek, R.A.2
Brandabur, J.J.3
-
19
-
-
79961129246
-
Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): A prospective, multicenter study
-
van Hooft JE, van Montfoort ML, Jeurnink SM et al. Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): a prospective, multicenter study. Endoscopy: 2011; 43 671 675
-
(2011)
Endoscopy
, vol.43
, pp. 671-675
-
-
Van Hooft, J.E.1
Van Montfoort, M.L.2
Jeurnink, S.M.3
-
20
-
-
76849083238
-
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer
-
Bayraktar S, Bayraktar UD, Rocha-Lima CM. Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. World J Gastroenterol: 2010; 16 673 682
-
(2010)
World J Gastroenterol
, vol.16
, pp. 673-682
-
-
Bayraktar, S.1
Bayraktar, U.D.2
Rocha-Lima, C.M.3
|